CAF interacts with specific genetic variants such as MAPT, SLC2A13, LRRK2, ApoE, NOS2A, GRIN2A, CYP1A2, and ADORA2A, which may influence the risk of developing Parkinson’s Disease (PD). The gene discussed is GRIN2A; the disease is Parkinson disease.